UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Behandlung und LDL-Cholesterin-Einstellung von Patienten mit hohem und sehr hohem kardiovaskulärem Risiko in Deutschland und im europäischen Vergleich – Daten des SANTORINI-Registers

Deutsche medizinische Wochenschrift, 2023-04, Vol.148 (9), p.55-64

2023

Volltextzugriff (PDF)

Low‐density lipoprotein cholesterol and lifespan: A Mendelian randomization study

British journal of clinical pharmacology, 2021-10, Vol.87 (10), p.3916-3924

2021

Volltextzugriff (PDF)

Male-specific Association between Iron and Lipid Metabolism Changes and Erythroferrone after Hepatitis C Virus Eradication

Internal Medicine, 2021, pp.7172-21

2021

Volltextzugriff (PDF)

Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan

Journal of Atherosclerosis and Thrombosis, 2023, pp.63940

2023

Volltextzugriff (PDF)

Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia

Clinical biochemistry, 2021-08, Vol.94, p.42-47

2021

Volltextzugriff (PDF)

A new dawn for managing dyslipidemias: The era of rna-based therapies

Pharmacological research, 2019-12, Vol.150, p.104413-104413, Article 104413

2019

Volltextzugriff (PDF)

Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024

The Medical clinics of North America, 2024-05, Vol.108 (3), p.441-453

2024

Volltextzugriff (PDF)

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Journal of the American College of Cardiology, 2016-07, Vol.68 (1), p.92-125

2016

Volltextzugriff (PDF)

Genetically predicted small dense low-density lipoprotein cholesterol and ischemic stroke subtype: multivariable Mendelian randomization study

Frontiers in endocrinology (Lausanne), 2024-07, Vol.15, p.1404234

2024

Volltextzugriff (PDF)

Cholesterol in LDL receptor recycling and degradation

Clinica chimica acta, 2020-01, Vol.500, p.81-86

2020

Volltextzugriff (PDF)

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2020-02, Vol.75 (6), p.565-574

2020

Volltextzugriff (PDF)

The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort

European journal of preventive cardiology, 2021-03, Vol.28 (1), p.47-56

2021

Volltextzugriff (PDF)

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Journal of the American Heart Association, 2023-08, Vol.12 (15), p.e030405-e030405

2023

Volltextzugriff (PDF)

Twin Study: The Factors Affecting the Serum LDL-C and HDL-C Levels and an RNA-Seq Analysis in Mononuclear Cells in Monozygotic Twins

Journal of Atherosclerosis and Thrombosis, 2024, pp.64882

2024

Volltextzugriff (PDF)

Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study

Diabetes, obesity & metabolism, 2020-10, Vol.22 (10), p.1777-1788

2020

Volltextzugriff (PDF)

Concordance between LDL-C estimated by various formulas and directly measured LDL-C

Journal of clinical lipidology, 2024-08

2024

Volltextzugriff (PDF)

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1350-1361

2015

Volltextzugriff (PDF)

The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials

Phytotherapy research, 2023-04, Vol.37 (4), p.1640-1662

2023

Volltextzugriff (PDF)

Hypercholesterolemia - non-pharmacological treatment, monotherapy or combination therapy. Review of the literature

Quality in Sport, 2024-08, Vol.19, p.54155

2024

Volltextzugriff (PDF)

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins

Clinical research in cardiology, 2018-05, Vol.107 (5), p.380-388

2018

Volltextzugriff (PDF)

Low‐Density Lipoprotein Cholesterol/High‐Density Lipoprotein Cholesterol Ratio and Carotid Intima‐Media Thickness: A Cohort Study in China

Lipids, 2021-01, Vol.56 (1), p.59-68

2021

Volltextzugriff (PDF)

The effect of phytosterol supplementation on lipid profile: A critical umbrella review of interventional meta‐analyses

Phytotherapy research, 2024-02, Vol.38 (2), p.507-519

2024

Volltextzugriff (PDF)

Dyslipidemia and peripheral arterial disease

Indian heart journal, 2024-03, Vol.76 (Suppl 1), p.S86-S89

2024

Volltextzugriff (PDF)

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver diseaseResearch in context

EBioMedicine, 2023-04, Vol.90, p.104543

2023

Volltextzugriff (PDF)

1 – 25 von 1.874

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.464)
Mit Volltextzugriff
(1.441)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.216)
Life Sciences & Biomedicine
(1.204)
Ldl-C
(1.047)
Humans
(989)
Male
(526)
Female
(513)
Cholesterol
(469)
Cholesterol, Ldl - Blood
(429)
Middle Aged
(416)
Cardiovascular System & Cardiology
(398)
Risk Factors
(313)
Cardiac & Cardiovascular Systems
(301)
Hdl-C
(289)
Lipids
(286)
Aged
(285)
Adult
(283)
Cardiovascular Disease
(274)
Statins
(274)
Triglycerides
(217)
Pharmacology & Pharmacy
(213)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Behandlung und LDL-Cholesterin-Einstellung von Patienten mit hohem und sehr hohem kardiovaskulärem Risiko in Deutschland und im europäischen Vergleich – Daten des SANTORINI-Registers

The singular French PCSK9-p.Ser127Arg gain-of-function variant: a significant player in cholesterol levels from a 775-year-old common ancestor

Low‐density lipoprotein cholesterol and lifespan: A Mendelian randomization study

Male-specific Association between Iron and Lipid Metabolism Changes and Erythroferrone after Hepatitis C Virus Eradication

Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan

Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia

A new dawn for managing dyslipidemias: The era of rna-based therapies

Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Genetically predicted small dense low-density lipoprotein cholesterol and ischemic stroke subtype: multivariable Mendelian randomization study

Cholesterol in LDL receptor recycling and degradation

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia

The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort

Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol

Twin Study: The Factors Affecting the Serum LDL-C and HDL-C Levels and an RNA-Seq Analysis in Mononuclear Cells in Monozygotic Twins

Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study

Concordance between LDL-C estimated by various formulas and directly measured LDL-C

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials

Hypercholesterolemia - non-pharmacological treatment, monotherapy or combination therapy. Review of the literature

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins

Low‐Density Lipoprotein Cholesterol/High‐Density Lipoprotein Cholesterol Ratio and Carotid Intima‐Media Thickness: A Cohort Study in China

The effect of phytosterol supplementation on lipid profile: A critical umbrella review of interventional meta‐analyses

Dyslipidemia and peripheral arterial disease

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver diseaseResearch in context

Suchergebnisse filtern